Global HEOR Strategist: Shape Access & Outcomes

Planet Pharma; Brussel; Presencial; EUR 90.000 - 140.000; Jornada completa

Descripción de la vacante

Planet Pharma is seeking a Global HEOR Expert to drive evidence generation and shape access strategies for therapies worldwide. You will lead cross-functional teams, design robust HEOR programs, and influence healthcare decision-makers across EU and ex-EU markets.

The role requires 5+ years in health economics/outcomes research, expertise in HTA and payer evidence, and strong stakeholder engagement. Willingness to travel is expected to support global launches and lifecycle initiatives.

Formación

• Minimum 5 years' experience in health economics/outcomes research in pharma or consulting.
• At least 3 years in global/regional oversight of access strategy and payer evidence.
• Expertise in health economics modeling, outcomes research, and HTA processes.
• Strong understanding of international healthcare ecosystems including EU markets.
• Excellent project management and stakeholder leadership.

Responsabilidades

• Lead global HEOR initiatives to support access and lifecycle management.
• Develop and implement health economics strategies for launches.
• Generate robust payer evidence and HTA submissions.
• Collaborate cross-functionally with commercial, medical, and regulatory teams.
• Engage externally with KOLs and academic partners.

Conocimientos

Health economics

Outcomes research

HTA

Payer evidence

Strategic leadership

Stakeholder engagement

Communication skills

Project management

Educación

Bachelor’s degree in healthcare/economics or related field

Advanced degree preferred (MSc, MD, PhD, PharmD)

Descripción del empleo

Planet Pharma is seeking a Global HEOR Expert to drive evidence generation and shape access strategies for therapies worldwide. You will lead cross-functional teams, design robust HEOR programs, and influence healthcare decision-makers across EU and ex-EU markets.

The role requires 5+ years in health economics/outcomes research, expertise in HTA and payer evidence, and strong stakeholder engagement. Willingness to travel is expected to support global launches and lifecycle initiatives.